Washington, DC, United States of America

Douglas M Gersten


Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1984-1987

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Douglas M. Gersten: Innovator in Metabolic Mapping and Protein Identification

Introduction

Douglas M. Gersten is a notable inventor based in Washington, DC. He has made significant contributions to the fields of metabolic mapping and protein identification, holding a total of 2 patents. His work has implications in medical imaging and biochemical analysis.

Latest Patents

Gersten's latest patents include innovative methods that enhance the understanding of biological processes. One of his patents focuses on "Radioopaque sugar derivatives and a method of metabolic mapping using computerized axial tomography." This method involves injecting a specific type of iodinated hexose into a mammalian body to visualize the concentration flux in the central nervous system through advanced imaging techniques. Another patent details a process for "Radioactive staining of gels to identify proteins." This method utilizes a radioactive stain composition to effectively identify proteins in gels, employing techniques such as gamma scintillation counting or radioautography for demonstration.

Career Highlights

Gersten is affiliated with Georgetown University, where he has contributed to research and development in his areas of expertise. His work has not only advanced scientific knowledge but also provided practical applications in medical diagnostics.

Collaborations

Throughout his career, Gersten has collaborated with esteemed colleagues, including Robert S. Ledley and Edward J. Zapolski. These partnerships have fostered innovation and have led to significant advancements in their respective fields.

Conclusion

Douglas M. Gersten's contributions to metabolic mapping and protein identification highlight his role as a key innovator in the scientific community. His patents reflect a commitment to advancing medical technology and improving diagnostic methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…